Researchers to use iPS cells to study Parkinson's disease

07/14/2010 | BBC

British researchers are undertaking a trial that will use induced pluripotent stem cells to understand Parkinson's disease. The researchers will obtain skin cells from 1,000 patients with early-stage disease and convert those cells into nerve cells containing the disease. "Once we have neurons from patients we can compare the functioning of cells taken from patients with the disease and those without to better understand why dopamine neurons die in patients with Parkinson's," a researcher said.

View Full Article in:

BBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX